MiR-335-5p inhibits the progression of head and neck squamous cell carcinoma by targeting MAP3K2

Abstract

Mounting evidence has indicated that aberrantly expressed microRNAs (miRNAs) play key roles in tumorigenesis, including in head and neck squamous cell carcinoma (HNSCC). Previous studies have shown that miR-335-5p can serve as a tumor suppressor or an oncogene in cancer. However, the clinical importance and biological effects of miR-335-5p in HNSCC have not been determined. Here, we investigated the expression pattern, functional role, and mechanisms of miR-335-5p in HNSCC. We showed a decreased expression of miR-335-5p in HNSCC samples from the TCGA and GEO databases. Consistently, we detected a downregulation of miR-335-5p in HNSCC cell lines and patient tissues. The expression of miR-335-5p was inversely correlated with advanced clinical TNM stage and lymph node metastasis in HNSCC patients. miR-335-5p overexpression inhibited HNSCC cell proliferation and induced apoptosis, while miR-335-5p inhibition had the opposite effects. miR-335-5p overexpression suppressed tumor growth in mice. Bioinformatic analyses and functional assays identified MAP3K2 as a target of miR-335-5p, and we showed that miR-335-5p downregulated mitogen-activated protein kinase kinase kinase 2 (MAP3K2) expression in HNSCC cells. We found an inverse association between MAP3K2 and miR-335-5p expression in 38 pairs of HNSCC tissues. Furthermore, the effect of miR-335-5p overexpression on growth and metastasis as well as cell apoptosis in HNSCC cells could be partially rescued by MAP3K2 expression. Collectively, our data show that miR-335-5p inhibits the development of HNSCC by regulating MAP3K2 expression. Thus, these findings offer novel insights into a potential therapeutic strategy for HNSCC patients.